Overview
Description
Scinai Immunotherapeutics Ltd is a biotechnology company engaged in the development of innovative immunotherapy solutions. The primary focus of Scinai Immunotherapeutics is to harness the power of the body's immune system to treat and potentially cure various diseases. This includes the development of therapies targeting infectious diseases, auto-immune disorders, and cancer. The company relies on cutting-edge research and collaborations with academic institutions and industry partners to advance its pipeline of products. Scinai Immunotherapeutics Ltd plays a crucial role in the biotechnology sector, contributing to advancements in personalized medicine and novel therapeutic approaches. Its work aligns with the growing trend in the healthcare industry towards precision medicine and targeted treatment options, representing a significant area of interest for medical professionals and researchers worldwide. By addressing unmet medical needs through innovative therapies, Scinai Immunotherapeutics Ltd aims to improve patient outcomes and quality of life, while also impacting the larger healthcare market with its scientific breakthroughs and advancements.
About
CEO
Mr. Amir Reichman M.B.A., M.Sc.
Employees
31
Address
Jerusalem BioPark
2nd floor Hadassah Ein Kerem Campus
Jerusalem
2nd floor Hadassah Ein Kerem Campus
Jerusalem
Phone
972 8 930 2529
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Biotechnology
Country
Germany
MIC code
XFRA